Europe has mostly been spared from the synthetic opioid crisis that has ravaged the U.S. over the past two decades. But now, a deadly new drug could be changing that: nitazenes. Up to 15 times stronger than fentanyl, nitazenes have been behind hundreds of overdose deaths in European countries over the past few years. WSJ's Sune Rasmussen on where the drug comes from and why it's doing so much damage. Jessica Mendoza hosts. Further Listening: Fentanyl Is Bad. ‘Tranq’ Might Be Worse. The Push to Test Drugs for Fentanyl Why Some Opioid Victims Are Challenging Purdue’s Settlement Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from The Journal.
Transcribed and ready to explore now
Medicare, Inc. Part 1: How Insurers Make Billions From Medicare
06 Jun 2025
The Journal.
Deportations Could Upend This Parachute Factory
05 Jun 2025
The Journal.
The Struggle to Get Aid Into Gaza
04 Jun 2025
The Journal.
The Everyday American Who Hustled for North Korea
03 Jun 2025
The Journal.
Stop Making Cents: The End of the Penny
02 Jun 2025
The Journal.
Ron Howard and Brian Grazer on Longevity in Hollywood
01 Jun 2025
The Journal.